CH25H and neoplasm: Compared to the Ch25hf/f mice, the subcutaneous tumors in the Ch25hf/fLyz2Cre(±) mice demonstrated a slower growth rate, along with reduced tumor volume and weight following the myeloid‐specific knockdown of CH25H.